Fellowship · Minneapolis, MN
Sponsored by University of Minnesota
Exploring the NK cell platform for cancer immunotherapy.
Nature reviews. Clinical oncology · 2021 · 1,073 citations · Jeffrey Miller
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 646 citations · Steven Powell
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
The New England journal of medicine · 2021 · 780 citations · Lisa Kreuziger
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet (London, England) · 2022 · 698 citations · Veronika Bachanova
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
The New England journal of medicine · 2021 · 743 citations · Lisa Kreuziger
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
European heart journal · 2022 · 517 citations ·
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
European urology · 2025 · 123 citations · Emmanuel Antonarakis
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.
Blood advances · 2023 · 206 citations · Lisa Kreuziger